Ruizhao Li

1.3k total citations
58 papers, 963 citations indexed

About

Ruizhao Li is a scholar working on Nephrology, Molecular Biology and Epidemiology. According to data from OpenAlex, Ruizhao Li has authored 58 papers receiving a total of 963 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Nephrology, 20 papers in Molecular Biology and 10 papers in Epidemiology. Recurrent topics in Ruizhao Li's work include Renal Diseases and Glomerulopathies (24 papers), Chronic Kidney Disease and Diabetes (11 papers) and Acute Kidney Injury Research (9 papers). Ruizhao Li is often cited by papers focused on Renal Diseases and Glomerulopathies (24 papers), Chronic Kidney Disease and Diabetes (11 papers) and Acute Kidney Injury Research (9 papers). Ruizhao Li collaborates with scholars based in China and United States. Ruizhao Li's co-authors include Xinling Liang, Yuanhan Chen, Shuangxin Liu, Zhiming Ye, Zhilian Li, Wenjian Wang, Wei Dong, Xingchen Zhao, Wei Shi and Xiaofan Tan and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Biochemical and Biophysical Research Communications.

In The Last Decade

Ruizhao Li

55 papers receiving 950 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruizhao Li China 18 407 396 161 118 110 58 963
Zhilian Li China 20 365 0.9× 381 1.0× 176 1.1× 137 1.2× 169 1.5× 64 1.0k
Kayo Okamura United States 20 367 0.9× 268 0.7× 128 0.8× 123 1.0× 71 0.6× 33 960
Paisit Paueksakon United States 16 393 1.0× 437 1.1× 260 1.6× 89 0.8× 71 0.6× 49 1.2k
Tomohito Doke United States 16 328 0.8× 427 1.1× 141 0.9× 130 1.1× 45 0.4× 24 937
Bryan R. Conway United Kingdom 20 451 1.1× 422 1.1× 98 0.6× 149 1.3× 181 1.6× 41 1.2k
Xuewang Li China 17 394 1.0× 292 0.7× 105 0.7× 134 1.1× 51 0.5× 81 915
Chun‐Tao Lei China 16 310 0.8× 353 0.9× 110 0.7× 74 0.6× 37 0.3× 26 908
Zeyuan Lu China 15 246 0.6× 249 0.6× 68 0.4× 63 0.5× 77 0.7× 29 715
Mei Tran United States 12 425 1.0× 589 1.5× 216 1.3× 68 0.6× 46 0.4× 13 1.2k
Anna Zdzienicka Poland 16 278 0.7× 261 0.7× 97 0.6× 102 0.9× 166 1.5× 39 980

Countries citing papers authored by Ruizhao Li

Since Specialization
Citations

This map shows the geographic impact of Ruizhao Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruizhao Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruizhao Li more than expected).

Fields of papers citing papers by Ruizhao Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruizhao Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruizhao Li. The network helps show where Ruizhao Li may publish in the future.

Co-authorship network of co-authors of Ruizhao Li

This figure shows the co-authorship network connecting the top 25 collaborators of Ruizhao Li. A scholar is included among the top collaborators of Ruizhao Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruizhao Li. Ruizhao Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Luan, Jiaying Li, Ruizhao Li, et al.. (2025). Podocyte RIPK3 Deletion Improves Diabetic Kidney Disease by Attenuating NF‐κB p65 Driven Inflammation. Advanced Science. 12(33). e03325–e03325. 1 indexed citations
2.
Cheng, Jie, et al.. (2024). Multi-functional photonic spin Hall effect sensor controlled by phase transition. Chinese Physics B. 33(7). 74203–74203. 5 indexed citations
3.
Li, Luan, Yingwen Chen, Qingying Shi, et al.. (2023). Role of TFEB in regulation of the podocyte actin cytoskeleton. Archives of Biochemistry and Biophysics. 747. 109752–109752. 1 indexed citations
4.
Yan, Yang, Luan Li, Qingying Shi, et al.. (2023). Growth associated protein 43 deficiency promotes podocyte injury by activating the calmodulin/calcineurin pathway under hyperglycemia. Biochemical and Biophysical Research Communications. 656. 104–114. 4 indexed citations
5.
Yu, Chunping, Hong Zhang, Shuangxin Liu, et al.. (2022). Flot2 acts as a novel mediator of podocyte injury in proteinuric kidney disease. International Journal of Biological Sciences. 19(2). 502–520. 6 indexed citations
6.
Zhang, Yuhua, Xingchen Zhao, Yan Yang, et al.. (2022). Aberrant NAD synthetic flux in podocytes under diabetic conditions and effects of indoleamine 2,3-dioxygenase on promoting de novo NAD synthesis. Biochemical and Biophysical Research Communications. 643. 61–68. 5 indexed citations
7.
Li, Ruizhao, Xingchen Zhao, Shu Zhang, et al.. (2021). RIP3 impedes transcription factor EB to suppress autophagic degradation in septic acute kidney injury. Cell Death and Disease. 12(6). 593–593. 27 indexed citations
8.
Zhang, Yifan, Qifeng Jiang, Jianteng Xie, et al.. (2021). Modified arteriosclerosis score predicts the outcomes of diabetic kidney disease. BMC Nephrology. 22(1). 281–281. 10 indexed citations
9.
Huang, Ying, Xingchen Zhao, Zhiyong Xie, et al.. (2020). Histone deacetylase 4 mediates high glucose-induced podocyte apoptosis via upregulation of calcineurin. Biochemical and Biophysical Research Communications. 533(4). 1061–1068. 16 indexed citations
10.
Li, Qiuling, Feng Wen, Yanhui Wang, et al.. (2020). Diabetic Kidney Disease Benefits from Intensive Low-Protein Diet: Updated Systematic Review and Meta-analysis. Diabetes Therapy. 12(1). 21–36. 24 indexed citations
11.
Zhang, Li, Wei Dong, Ruizhao Li, et al.. (2020). Raised Plasma Levels of Asymmetric Dimethylarginine Are Associated with Pathological Type and Predict the Therapeutic Effect in Lupus Nephritis Patients Treated with Cyclophosphamide. SHILAP Revista de lepidopterología. 6(5). 355–363. 4 indexed citations
12.
Ye, Zhiming, Li Zhang, Ruizhao Li, et al.. (2019). Caspase-11 Mediates Pyroptosis of Tubular Epithelial Cells and Septic Acute Kidney Injury. Kidney & Blood Pressure Research. 44(4). 465–478. 71 indexed citations
13.
Lin, Ting, Li Zhang, Shuangxin Liu, et al.. (2017). WWC1 promotes podocyte survival via stabilizing slit diaphragm protein dendrin. Molecular Medicine Reports. 16(6). 8685–8690. 9 indexed citations
14.
Dong, Wei, Zhilian Li, Yuanhan Chen, et al.. (2017). NADPH oxidase inhibitor, diphenyleneiodonium prevents necroptosis in HK-2 cells. Biomedical Reports. 7(3). 226–230. 15 indexed citations
15.
Zhang, Hong, Shun Liang, Yue Du, et al.. (2017). Inducible ATF3–NFAT axis aggravates podocyte injury. Journal of Molecular Medicine. 96(1). 53–64. 20 indexed citations
16.
Zhuo, Li, Li Zhang, Wei Shi, et al.. (2015). Spironolactone inhibits podocyte motility via decreasing integrin β1 and increasing integrin β3 in podocytes under high-glucose conditions. Molecular Medicine Reports. 12(5). 6849–6854. 14 indexed citations
17.
Li, Zhilian, Lu Cai, Xinling Liang, et al.. (2014). Identification and Predicting Short-Term Prognosis of Early Cardiorenal Syndrome Type 1: KDIGO Is Superior to RIFLE or AKIN. PLoS ONE. 9(12). e114369–e114369. 36 indexed citations
18.
Ma, Jianchao, Bin Zhang, Shuangxin Liu, et al.. (2013). 1,25-Dihydroxyvitamin D(3) Inhibits Podocyte uPAR Expression and Reduces Proteinuria. PLoS ONE. 8(5). e64912–e64912. 16 indexed citations
19.
Li, Ruizhao, Li Zhang, Wei Shi, et al.. (2013). NFAT2 mediates high glucose-induced glomerular podocyte apoptosis through increased Bax expression. Experimental Cell Research. 319(7). 992–1000. 41 indexed citations
20.
Li, Zhilian, Shuangxin Liu, Xinling Liang, et al.. (2013). Pulmonary hypertension as an independent predictor of cardiovascular mortality and events in hemodialysis patients. International Urology and Nephrology. 46(1). 141–149. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026